Papers and Presentations
How to use Search
You can use search for sourcing a variety of content on the CASSS website. CASSS makes available any content with author approval.
Refine Results
Filter By Content Type
Filter By Resource Type
Filter By Tags
-
'Reliance' on Inspections: Not Just a Buzzword but a Real Opportunity
Speaker Presentation Raviol Holger, F. Hoffmann La Roche Ltd., 2021
-
Accelerated Technology Transfer to Meet Demand for a Repurposed Biologic: Challenges, Successes and Lessons Learned
Speaker Presentation Raviol Holger, F. Hoffmann La Roche Ltd., 2021
-
Regulatory Issues in the Context of Health Emergencies - Learnings and Recommendations
Speaker Presentation Lumsden Rebecca, Pfizer Limited, 2021
-
Expedited Product Development: Application of Regulatory Lessons Learned
Speaker Presentation Levis Robin, CBER, FDA, 2021
-
RBD-specific Polyclonal F(ab')2 Fragments of Equine Antibodies Improve Survival in Severe Patients Hospitalized with COVID-19
Speaker Presentation Goldbaum Fernando, Inmunova S.A., 2021
-
Pandemic Preparedness: Regulatory Agility in the Era of COVID-19 - Latin America
Speaker Presentation Fernandes Jason, Health Canada, 2021
-
Regulatory Perspectives on the Accelerated Development of Bamlanivimab - a SARS-CoV-2 Neutralizing Antibody
Speaker Presentation Dobbins JR, Eli Lilly and Company, 2021
-
Reliance, Virtual Inspections and Regulations - Brazilian Strategies During COVID-19 Pandemic
Speaker Presentation Ihatanderson Alves da Silva, ANVISA-National Health Surveillance Agency, 2021
-
More Structured, Interactive Process to Drive Convergence in Latin America Advocated by Biotech Product Regulators and Industry at CMC Strategy Forum in Brasilia
CMC Summary Paper: CMC Strategy Forum Latin America 2015
View On Demand Content
To view the content, visit https://casss.digitellinc.com, login to your account, and select the meeting from the list of past events. Visit the On Demand Presentations and Speaker Slides tab to view available content.
For 2021 meetings, content will be available for one year after the program. For 2022 and beyond, content will be available for three months.